InHANSE Institute of Head and Neck Studies and Education Contact Us

Prof Mehanna interview with eCancer Conferences

At this years ESMO conference in Munich, Professor Mehanna talked to eCancer about the results of the De-ESCALaTE study in which he reported that patients with HPV-positive oropharynx cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy.  You can see the interview here.

Charity appeal

Find out more about our £1m Charity appeal for the AcceleraTED cancer Treatment programme.